Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 06, 2019

SELL
$13.32 - $24.35 $533,505 - $975,290
-40,053 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$13.2 - $16.43 $528,699 - $658,070
40,053 New
40,053 $605,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.45B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Dc Investments Management, LLC Portfolio

Follow Dc Investments Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dc Investments Management, LLC with notifications on news.